Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Agoram, Balaji
32  Ergebnisse:
Personensuche X
?
1

Nonclinical drug development:

, In: Atkinson's Principles of Clinical Pharmacology,
Takimoto, Chris H. ; Wick, Michael J. ; Agoram, Balaji. - p. 573-588 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Contributors:

, In: Atkinson's Principles of Clinical Pharmacology,
Abernethy, Darrell R. ; Agoram, Balaji ; Allen, John M.... - p. xvii-xx , 2022
Link: https://doi.org/10.1016/..
 
?
3

Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab..:

Ly, Neang ; Zheng, Yanan ; Griffiths, Janet M....
The Journal of Clinical Pharmacology.  61 (2021)  7 - p. 901-912 , 2021
Link: https://doi.org/10.1002/..
 
?
4

Book Review: ADME and Translational Pharmacokinetics/Pharma..:

Agoram, Balaji
CPT: Pharmacometrics & Systems Pharmacology.  6 (2017)  6 - p. 355-356 , 2017
Link: https://doi.org/10.1002/..
 
?
5

Tralokinumab pharmacokinetics and tolerability when adminis..:

Jain, Meena ; Doughty, Diane ; Clawson, Corbin...
Int. Journal of Clinical Pharmacology and Therapeutics.  55 (2017)  7 - p. 606-620 , 2017
Link: https://doi.org/10.5414/..
 
?
6

Dose‐Exposure‐Response Relationship of the Investigational ..:

Baverel, Paul G. ; White, Nicholas ; Vicini, Paolo..
Clinical Pharmacology & Therapeutics.  103 (2017)  5 - p. 826-835 , 2017
Link: https://doi.org/10.1002/..
 
?
7

The application of mathematical modelling to the design of ..:

van Steeg, Tamara J. ; Bergmann, Kirsten Riber ; Dimasi, Nazzareno..
mAbs.  8 (2016)  3 - p. 585-592 , 2016
Link: https://doi.org/10.1080/..
 
?
8

Pharmacokinetics of tralokinumab in adolescents with asthma..:

Baverel, Paul G. ; Jain, Meena ; Stelmach, Iwona...
British Journal of Clinical Pharmacology.  80 (2015)  6 - p. 1337-1349 , 2015
Link: https://doi.org/10.1111/..
 
?
9

At the bench: the key role of PK-PD modelling in enabling t..:

Penney, Mark ; Agoram, Balaji
British Journal of Clinical Pharmacology.  77 (2014)  5 - p. 740-745 , 2014
Link: https://doi.org/10.1111/..
 
?
10

Inhalation by Design: Novel Tertiary Amine Muscarinic M3 Re..:

Glossop, Paul A. ; Watson, Christine A. L. ; Price, David A....
Journal of Medicinal Chemistry.  54 (2011)  19 - p. 6888-6904 , 2011
Link: https://doi.org/10.1021/..
 
?
11

Investigation of the effects of altered receptor binding ac..:

Agoram, Balaji ; Aoki, Ken ; Doshi, Sameer...
Journal of Pharmaceutical Sciences.  98 (2009)  6 - p. 2198-2211 , 2009
Link: https://doi.org/10.1002/..
 
?
12

Agoram B, Aoki K, Sameer Doshi, Gegg C, Jang G, Molineux G,..:

Agoram, Balaji ; Aoki, Ken ; Doshi, Sameer...
Journal of Pharmaceutical Sciences.  98 (2009)  10 - p. 3877 , 2009
Link: https://doi.org/10.1002/..
 
?
13

Population pharmacokinetics of darbepoetin alfa in healthy ..:

Agoram, Balaji ; Sutjandra, Liviawati ; Sullivan, John T.
British Journal of Clinical Pharmacology.  63 (2006)  1 - p. 41-52 , 2006
Link: https://doi.org/10.1111/..
 
?
14

Development and evaluation of a population pharmacokinetic-..:

Agoram, Balaji ; Heatherington, Anne C. ; Gastonguay, Marc R.
The AAPS Journal.  8 (2006)  3 - p. E552-E563 , 2006
Link: https://doi.org/10.1208/..
 
?
15

Predicting the impact of physiological and biochemical proc..:

Agoram, Balaji ; Woltosz, Walter S. ; Bolger, Michael B.
Advanced Drug Delivery Reviews.  50 (2001)  - p. S41-S67 , 2001
Link: https://doi.org/10.1016/..
 
1-15